We characterized LSN3213128 in three cell lines; the triple negative breast cancer cell line MDA-MB-231, the purine salvage deficient murine A9 tumor line, and the LKB1 mutant NCI-H460. This evidence concerns the gene STK11 and triple-negative breast carcinoma.